famotidine has been researched along with Brain Neoplasms in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, Y | 1 |
| Bae, SJ | 1 |
| Katayama, I | 1 |
| Hayashi, Y | 1 |
1 other study available for famotidine and Brain Neoplasms
| Article | Year |
|---|---|
Unusual erythemas with eosinophilia, caused by H2-blocker famotidine in a male patient with glioblastoma.
Topics: Aged; Biopsy, Needle; Brain Neoplasms; Eosinophilia; Erythema; Famotidine; Follow-Up Studies; Gliobl | 2004 |